You are here: Industry Insights > Allocetra

News List

Enlivex: After Review of Phase II Data, Israeli Ministry of Health Authorizes Initiation of a Multi-Center, Randomized Phase IIb Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Pat firstwordpharma
August 16, 2021
Enlivex Therapeutics Ltd. today reported that after reviewing previously-reported Phase II trial data, the Israeli Ministry of Health has authorized the initiation of a proposed Company-sponsored, multi-center, placebo-controlled, randomized, blinded
Vaxart’s oral vaccine candidate triggers immune response in Covid-19 trial pharmaceutical-technology
February 05, 2021
Vaxart has reported preliminary data from its Phase I study that showed its oral Covid-19 tablet vaccine candidate, VXA-CoV2-1, triggered multiple immune responses against SARS-CoV-2 antigens.
Israeli Ministry of Health Authorizes Trial Evaluating Allocetra in Sepsis Patients americanpharmaceuticalreview
November 12, 2020
Enlivex Therapeutics reported the Israeli Ministry of Health authorized the initiation of a proposed Company-sponsored Phase IIb clinical trial evaluating Allocetra™, in sepsis patients.
Enlivex Doses First Two Patients in Allocetra Trial in Severe COVID-19 Patients americanpharmaceuticalreview
October 29, 2020
Enlivex Therapeutics reported the first two patients have been dosed in an investigator-initiated Phase II clinical trial evaluating Allocetra in severe and critical COVID-19 patients.
Israeli Ministry of Health Authorizes Trial Initiation Evaluating Allocetra for COVID-19 americanpharmaceuticalreview
October 21, 2020
Enlivex Therapeutics reported that the Israeli Ministry of Health authorized the initiation of a proposed investigator-initiated Phase II clinical trial evaluating Allocetra in severe and critical COVID-19 patients.
Enlivex Announces First Patient Dosed in Allocetra Trial for COVID-19 with Respiratory Failure americanpharmaceuticalreview
August 13, 2020
Enlivex Therapeutics announced the first patient has been dosed in an investigator-initiated multi-center clinical trial of AllocetraTM in COVID-19 patients with severe illness and respiratory failures.
Enlivex Announces Trial Initiation of Allocetra in COVID-19 Patients americanpharmaceuticalreview
May 12, 2020
Enlivex Therapeutics announced an investigator-initiated multi-center Phase II clinical trial of Allocetra in COVID-19 patients has commenced.
Enlivex Initiates Phase II Trial of Allocetra in COVID-19 contractpharma
May 08, 2020
Will assess Allocetra in combination with therapy in patients with lung dysfunction.
Enlivex Announces Positive Final Safety and Efficacy Data from Allocetra Study americanpharmaceuticalreview
March 20, 2020
Enlivex Therapeutics announced positive final safety and efficacy data from the Company’s completed Phase Ib clinical trial in patients with severe sepsis.